Michelle F. Jacobs

575 total citations
35 papers, 235 citations indexed

About

Michelle F. Jacobs is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Michelle F. Jacobs has authored 35 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Michelle F. Jacobs's work include BRCA gene mutations in cancer (10 papers), Genetic factors in colorectal cancer (7 papers) and Genomics and Rare Diseases (5 papers). Michelle F. Jacobs is often cited by papers focused on BRCA gene mutations in cancer (10 papers), Genetic factors in colorectal cancer (7 papers) and Genomics and Rare Diseases (5 papers). Michelle F. Jacobs collaborates with scholars based in United States, United Kingdom and Ethiopia. Michelle F. Jacobs's co-authors include Elena M. Stoffel, Todd M. Morgan, Simpa S. Salami, Samuel D. Kaffenberger, Daniel E. Spratt, Erika Koeppe, Tobias Else, Eun-Young Choi, Henry D. Appelman and Sandra L. Wong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Michelle F. Jacobs

31 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle F. Jacobs United States 8 78 68 60 60 55 35 235
Vanja Filipovski North Macedonia 9 58 0.7× 43 0.6× 77 1.3× 32 0.5× 40 0.7× 21 307
Giulia Dondi Italy 11 46 0.6× 45 0.7× 46 0.8× 11 0.2× 31 0.6× 31 402
Rabea Wagener Germany 8 38 0.5× 37 0.5× 64 1.1× 57 0.9× 66 1.2× 26 236
Riitta Koivisto-Korander Finland 10 157 2.0× 67 1.0× 65 1.1× 29 0.5× 30 0.5× 18 404
Susanne Markmann Germany 8 39 0.5× 120 1.8× 40 0.7× 50 0.8× 63 1.1× 23 305
Olfa Gharbi Tunisia 11 39 0.5× 174 2.6× 48 0.8× 33 0.6× 92 1.7× 41 308
Shulamit Rizel Israel 11 42 0.5× 129 1.9× 91 1.5× 127 2.1× 91 1.7× 24 408
Sushanta K. Banerjee United States 9 152 1.9× 51 0.8× 67 1.1× 25 0.4× 44 0.8× 10 359

Countries citing papers authored by Michelle F. Jacobs

Since Specialization
Citations

This map shows the geographic impact of Michelle F. Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle F. Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle F. Jacobs more than expected).

Fields of papers citing papers by Michelle F. Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle F. Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle F. Jacobs. The network helps show where Michelle F. Jacobs may publish in the future.

Co-authorship network of co-authors of Michelle F. Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle F. Jacobs. A scholar is included among the top collaborators of Michelle F. Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle F. Jacobs. Michelle F. Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Florou, Vaia, Michelle F. Jacobs, Ruth Casey, et al.. (2025). A Review of Genomic Testing and SDH‐ Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST. Cancer Medicine. 14(3). e70669–e70669.
2.
Mazhar, Sahar, Caitlin M. O’Connor, Peter Ulintz, et al.. (2025). Germline mutations in PPP2R1B in patients with a personal and family history of cancer. JCI Insight. 10(9). 1 indexed citations
3.
Jacobs, Michelle F., Samuel D. Kaffenberger, Simpa S. Salami, et al.. (2024). Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing. Urology Practice. 12(1). 63–72. 1 indexed citations
4.
Weil, Jon, et al.. (2024). Promoting international, locally focused, and patient-oriented genetic counseling. SHILAP Revista de lepidopterología. 2(Suppl 2). 101880–101880. 1 indexed citations
5.
Jacobs, Michelle F., et al.. (2023). Implementation of a dedicated cascade testing clinic for patients at risk for hereditary cancer syndromes. Journal of Genetic Counseling. 33(5). 1035–1044. 1 indexed citations
6.
Seibert, Tyler M., Isla P. Garraway, Anna Plym, et al.. (2023). Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. European Urology. 83(3). 241–248. 24 indexed citations
7.
Maurer, Lisa M., Claire M. Julian, Nathanael G. Bailey, et al.. (2022). BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma. Cancer Research Communications. 2(4). 220–232. 10 indexed citations
8.
9.
Jacobs, Michelle F., et al.. (2022). A retrospective cohort study of genetic referral and diagnosis of Lynch syndrome in patients with cutaneous sebaceous lesions. Familial Cancer. 22(3). 295–301. 4 indexed citations
10.
Koeppe, Erika, et al.. (2021). Outcomes of retesting in patients with previously uninformative cancer genetics evaluations. Familial Cancer. 21(3). 375–385. 7 indexed citations
11.
Greenberg, Samantha, Michelle F. Jacobs, Heather Wachtel, et al.. (2020). Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma–pheochromocytoma syndrome. Genetics in Medicine. 22(12). 2101–2107. 18 indexed citations
12.
Jacobs, Michelle F., et al.. (2020). Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia. Hormones and Cancer. 11(5-6). 250–255. 13 indexed citations
13.
Scott, Anthony, et al.. (2020). Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series. Familial Cancer. 20(1). 61–65. 4 indexed citations
14.
Cobain, Erin F., Michelle F. Jacobs, Yi‐Mi Wu, et al.. (2020). Tumor/normal genomic profiling in patients with metastatic solid tumors identifies pathogenic germline variants of therapeutic importance.. Journal of Clinical Oncology. 38(15_suppl). 1501–1501. 1 indexed citations
15.
Jacobs, Michelle F., et al.. (2019). Hepatosplenic αβ T-Cell Lymphoma as Second Malignancy in Young Adult Patient With Previously Undiagnosed Ataxia-Telangiectasia. Journal of Pediatric Hematology/Oncology. 42(6). e463–e465. 6 indexed citations
16.
Jacobs, Michelle F. & Kara J. Milliron. (2019). Genetic counseling and previvorship in patients with urologic malignancies. Current Opinion in Urology. 29(4). 371–377. 5 indexed citations
17.
Stoffel, Elena M., Erika Koeppe, Kristen Hanson, et al.. (2016). Sa1765 Incidental Finding of Germline CDH1 Mutations: Implications for Clinical Management. Gastroenterology. 150(4). S360–S360. 1 indexed citations
18.
Reece, Ashley & Michelle F. Jacobs. (2008). Does drinking "flat" cola prevent dehydration in children with acute gastroenteritis?. Archives of Disease in Childhood.
19.
20.
Daugschies, Arwid, Michelle F. Jacobs, & M Rommel. (1989). [Heart failure in a pig chronically infected with Sarcocystis miescheriana--a case report].. PubMed. 102(6). 184–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026